US$ 26.04
long term effects of glp-1 agonists The cardiovascular receptor beyond obesity and type 2 diabetes: An anti-atherosclerotic action GLP-1 Receptor Agonists | New
Description
1,2 For this reason, its important to further understand the mechanism of GLP-1 therapies, said Lorenzo Leggio, a neuroendocrinologist at the National Institute on Drug Abuse who mediated the GLP-1 press conference at the 2025 Society for Neuroscience meeting

J.et al (2022)

[Google Scholar] 152.Macconell L, Brown C, Gurney K, Han J
Two new weight-loss pills The Wegovy pill was approved in December, and the speed with which people started using it broke records, according to one Wall Street firm, which said it became the fastest drug launch in history

Treasure Island: StatPearls Publishing

To solve this issue, researchers developed a more chemically stable synthetic version known as Extendin, which they then combined with a mildly radioactive tracer used in standard PET scans